Skip to main content
Clinical Trials/NCT04215081
NCT04215081
Completed
N/A

ExoAtlet II Lower Extremity Exoskeleton Safety and Efficacy Use With Spinal Cord Injured Individuals

ExoAtlet1 site in 1 country20 target enrollmentNovember 18, 2019

Overview

Phase
N/A
Intervention
Not specified
Conditions
Spinal Cord Injuries
Sponsor
ExoAtlet
Enrollment
20
Locations
1
Primary Endpoint
Number of adverse events
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This study will evaluate the ExoAtlet II exoskeleton for safety and effectiveness of providing persons with a spinal cord injury (SCI) who are non-ambulatory or have limited ambulatory function, to stand up and ambulate under a variety of conditions.

Detailed Description

The study will introduce the ExoAtlet II exoskeleton to SCI patients with lower extremity paralysis (partial or complete) and provide rehabilitative standing and walking intervention. The study will be conducted with a trained clinician that will fit each patient into the adjustable exoskeleton system and provide customized programming to meet each user's specific needs. The training program will be initiated based upon each patient's comfort in the exoskeleton and ability to stand with assistance. Each patient will be closely monitored to assess ongoing health as well as their individual standing and walking ability. All exoskeleton sessions will be performed with a trained medical professional controlling the exoskeleton. Patient safety is the primary concern and all adverse events will be documented and addressed. This study will evaluate the ExoAtlet 2.0 exoskeleton for safety and effectiveness of providing persons with a spinal cord injury (SCI) who are non-ambulatory or have limited ambulatory function, the ability to stand up and walk in a clinical facility.

Registry
clinicaltrials.gov
Start Date
November 18, 2019
End Date
January 4, 2020
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
ExoAtlet
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • 18 Years of age or older in general good health
  • Weight, no more than 220lbs (100kg)
  • Skin must be healthy where it touches the ExoAtlet 2.0
  • Able to stand using a device such as a standing frame
  • Have enough strength in your hands and shoulders to support yourself standing and walking using crutches or a walker
  • Have good control of upper body
  • Determined to have enough bone health to walk full weight bearing without risk of fracture. Meeting of this condition is at the discretion of your personal MD
  • Passive range of motion (PROM) at shoulders, trunk, upper extremities and lower extremities within functional limits for safe gait and use of appropriate assistive device/stability aid
  • Hip width no greater than 18" (46 cm) measured when sitting.
  • Femur length between 37 cm and 49 cm measured between mid patellar tendon and the floor.

Exclusion Criteria

  • Spinal cord injury level higher than T4 or C7 ASIA D
  • Severe muscle stiffness/tightness
  • Significant spasticity (Modified Ashworth Scale score of 3 or above)
  • Trunk or lower extremity pressure ulcer
  • Open Wounds/tissue hypersensitivity
  • Unstable spine, un-healed limbs, or fractures
  • Severe sensitivity to touch
  • Presence of bone in soft tissue where bone normally does not exist (heterotopic ossification), limiting range of motion in the hip or knee joints
  • Joint instability, dislocation, moderate to severe hip dysplasia
  • Significant scoliosis (\>40 degrees)

Outcomes

Primary Outcomes

Number of adverse events

Time Frame: 0-8 weeks

Document and track any adverse events, both minor and major, during exoskeleton sessions.

Skin integrity

Time Frame: 0-8 weeks

A visual inspection of the participant's skin, at all areas of contact with the exoskeleton, will be conducted at the beginning and end of each session.

Secondary Outcomes

  • 10 Meter Walk Test(1 Day)
  • Transfer in and out(2 Days)
  • 6 Minute Walk Test(1 Day)
  • Perform Sit to Stand to Sit(2 Days)

Study Sites (1)

Loading locations...

Similar Trials